TETAGAM-P

This brand name is authorized in Austria, Estonia, Hong Kong SAR China, Ireland, Malta, Romania, South Africa, Tunisia, Turkey.

Active ingredients

The drug TETAGAM-P contains one active pharmaceutical ingredient (API):

1	Immunoglobulin human anti-tetanus UNII V4SWI4RF4J - HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN
	Human tetanus immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against the toxin produced by the bacteria clostridium tetanus.
	Read more about Tetanus immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TETAGAM-P Solution for injection	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J06BB02	Tetanus immunoglobulin	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1253113, 1638637
HK	Department of Health Drug Office	51935
MT	Medicines Authority	MA665/00801, MA665/00802
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67888001
TN	Direction de la Pharmacie et du Médicament	8143032, 8143033
TR	İlaç ve Tıbbi Cihaz Kurumu	8681624980170
ZA	Health Products Regulatory Authority	T/30.2/0743, T/30.2/0744